Global Erythropoietin Drugs Market was worth USD 9.06 billion in 2017 and estimated to be growing at a CAGR of 9.7%, to reach USD 14.32 billion by 2022. Erythropoietin is present in the bone marrow cells controlling the production of red blood cells. They can be used for the treatment of anaemia, HIV and Cancer. Various synthetic forms of erythropoietin are available in the market due to advancements in recombinant DNA technology.

Browse full report @ https://www.marketdataforecast.com/market-reports/erythropoietin-drugs-market-6767/

Increased incidence of anaemia, rising commercialisation of EPO drugs and favourable reimbursement policies are further driving the market growth. As cheaper biosimilars are also available the market is expected to propel during the forecast period.

Request sample report @ https://www.marketdataforecast.com/market-reports/erythropoietin-drugs-market-6767/request-sample

 Market Segmentation                                              

               Product                        

• Introduction           
• Epoetin-alfa            
• Epoetin-beta          
• Darbepoetin-alfa  

 

              Application                 

• Introduction           
• Cancer      
• Hematology            
• Renal diseases       

 

              Drug class                    

• Introduction           
• Biologics   
• Biosimilars      

         

Inquire before buying @ https://www.marketdataforecast.com/market-reports/erythropoietin-drugs-market-6767/inquire

The market for Erythropoietin Drugs is broadly categorized into product, application and drug class. By product the market is divided into Epoetin-alpha, epoetin-beta, darbepoetin-alfa and others. Epoietin-alfa holds the largest market share. By application the market is classified into cancer, haematology, renal diseases and neurology. Cancer segment is predicted to be fastest growing segment. By drug class the market is segmented into biologics and biosimilar. Biosimilars are predicted to grow at a significant rate during the forecast period. On the basis of geography, the market is analysed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Erythropoietin Drugs market was dominated by Europe followed closely by North America. Asia Pacific is expected to grow at a high CAGR.

Request discount @ https://www.marketdataforecast.com/market-reports/erythropoietin-drugs-market-6767/request-discount

Some of the major companies dominating the market, by their products and services include Johnson & Johnson, Celltrion, Inc, Teva Pharmaceutical Industries Ltd. , Sun Pharmaceutical Industries Ltd. , Dr. Reddy’s Laboratories Ltd.Amgen, Inc. , F. Hoffmann-La Roche Ltd. , LG Life Sciences Ltd. , Biocon Limited  and Intas Pharmaceuticals Ltd.

Buy now full report @ https://www.marketdataforecast.com/cart/buy-now/erythropoietin-drugs-market-6767

About Market Data Forecast:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases